Cancer cytopathology
-
Cancer cytopathology · Feb 2018
Comparative StudyProgrammed death-ligand 1 testing of lung cancer cytology specimens obtained with bronchoscopy.
Programmed death-ligand 1 (PD-L1) expression testing is recommended by guidelines for patients with advanced non-small cell lung cancer (NSCLC). The primary objective of the current study was to determine the success rate of PD-L1 testing from cytology cell block samples obtained by bronchoscopic needle aspiration. The secondary objective was the assessment of the difference in specimen adequacy acquired via needles of different gauges. ⋯ Bronchoscopically obtained cytology needle-based samples are adequate for PD-L1 testing in patients with NSCLC. There was no difference noted between different needle sizes with regard to adequacy for PD-L1 testing. These findings are relevant for clinicians caring for patients with lung cancer because a vast majority of patients with advanced NSCLC are diagnosed by bronchoscopic needle-based techniques using a variety of commercially available needles. Cancer Cytopathol 2018;126:122-8. © 2017 American Cancer Society.
-
Cancer cytopathology · Feb 2018
Comparative StudyThe utility of adaptive eLearning in cervical cytopathology education.
Adaptive eLearning allows students to experience a self-paced, individualized curriculum based on prior knowledge and learning ability. ⋯ Overall, the modules were viewed positively by participants. Adaptive eLearning modules can provide an engaging and effective adjunct to traditional teaching methods in cervical cytopathology. Cancer Cytopathol 2018;126:129-35. © 2017 American Cancer Society.